MENU
+Compare
RXRX
Stock ticker: NASDAQ
AS OF
Oct 6, 04:59 PM (EDT)
Price
$5.53
Change
+$0.04 (+0.73%)
Capitalization
2.4B

RXRX Recursion Pharmaceuticals Forecast, Technical & Fundamental Analysis

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company... Show more

RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RXRX with price predictions
Oct 03, 2025

RXRX's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for RXRX turned positive on September 11, 2025. Looking at past instances where RXRX's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 29, 2025. You may want to consider a long position or call options on RXRX as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

RXRX moved above its 50-day moving average on October 02, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where RXRX advanced for three days, in of 244 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 129 cases where RXRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RXRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RXRX broke above its upper Bollinger Band on October 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.608) is normal, around the industry mean (23.241). P/E Ratio (0.000) is within average values for comparable stocks, (54.537). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.239). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (30.581) is also within normal values, averaging (354.169).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RXRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RXRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RXRX is expected to report earnings to fall 17.07% to -34 cents per share on November 05

Recursion Pharmaceuticals RXRX Stock Earnings Reports
Q3'25
Est.
$-0.34
Q2'25
Missed
by $0.06
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.12
Q3'24
Missed
by $0.01
The last earnings report on August 05 showed earnings per share of -40 cents, missing the estimate of -34 cents. With 20.05M shares outstanding, the current market capitalization sits at 2.40B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
41 S Rio Grande Street
Phone
+1 385 269-0203
Employees
500
Web
https://www.recursion.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIVIX24.450.23
+0.95%
Causeway International Value Instl
GSQTX36.310.21
+0.58%
Goldman Sachs Small Cap Value Inv
HSLAX41.080.18
+0.44%
Hartford Small Cap Growth A
TRGRX17.650.06
+0.34%
T. Rowe Price Global Real Estate
INDZX18.540.03
+0.16%
Columbia Intrinsic Value A

RXRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-0.54%
CRSP - RXRX
69%
Closely correlated
-6.98%
ABSI - RXRX
63%
Loosely correlated
-4.79%
BEAM - RXRX
61%
Loosely correlated
+0.63%
ABCL - RXRX
57%
Loosely correlated
-1.34%
NTLA - RXRX
55%
Loosely correlated
-2.35%
More

Groups containing RXRX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-0.54%
RXRX
(2 stocks)
78%
Closely correlated
+2.13%